- Home
- AIXI vs DTIL Comparison
AIXI vs DTIL Comparison
Compare AIXI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- DTIL
- Stock Information
- Founded
- AIXI 2001
- DTIL 2006
- Country
- AIXI China
- DTIL United States
- Employees
- AIXI N/A
- DTIL N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- AIXI Technology
- DTIL Health Care
- Exchange
- AIXI Nasdaq
- DTIL Nasdaq
- Market Cap
- AIXI 43.9M
- DTIL 43.3M
- IPO Year
- AIXI 2023
- DTIL 2019
- Fundamental
- Price
- AIXI $4.00
- DTIL $4.71
- Analyst Decision
- AIXI
- DTIL Strong Buy
- Analyst Count
- AIXI 0
- DTIL 3
- Target Price
- AIXI N/A
- DTIL $37.67
- AVG Volume (30 Days)
- AIXI 61.8K
- DTIL 132.0K
- Earning Date
- AIXI 04-29-2025
- DTIL 03-26-2025
- Dividend Yield
- AIXI N/A
- DTIL N/A
- EPS Growth
- AIXI N/A
- DTIL N/A
- EPS
- AIXI N/A
- DTIL 1.04
- Revenue
- AIXI $65,643,604.00
- DTIL $68,696,000.00
- Revenue This Year
- AIXI $22.85
- DTIL N/A
- Revenue Next Year
- AIXI $22.70
- DTIL $58.46
- P/E Ratio
- AIXI N/A
- DTIL $4.51
- Revenue Growth
- AIXI 6.22
- DTIL 40.98
- 52 Week Low
- AIXI $2.06
- DTIL $3.61
- 52 Week High
- AIXI $16.65
- DTIL $15.33
- Technical
- Relative Strength Index (RSI)
- AIXI 46.12
- DTIL 43.75
- Support Level
- AIXI $3.82
- DTIL $4.25
- Resistance Level
- AIXI $4.40
- DTIL $4.99
- Average True Range (ATR)
- AIXI 0.41
- DTIL 0.40
- MACD
- AIXI 0.04
- DTIL -0.05
- Stochastic Oscillator
- AIXI 58.72
- DTIL 31.29
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.